Distinct PD-L1/PD1 Profiles and Clinical Implications in Intrahepatic Cholangiocarcinoma Patients with Different Risk Factors

Jia-Cheng Lu,Hai-Ying Zeng,Qi-Man Sun,Qing-Nan Meng,Xiao-Yong Huang,Peng-Fei Zhang,Xuan Yang,Rui Peng,Chao Gao,Chuan-Yuan Wei,Ying-Hao Shen,Jia-Bing Cai,Rui-Zhao Dong,Ying-Hong Shi,Hui-Chuan Sun,Yujiang G Shi,Jian Zhou,Jia Fan,Ai-Wu Ke,Liu-Xiao Yang,Guo-Ming Shi,Yujiang G. Shi
DOI: https://doi.org/10.7150/thno.36276
IF: 11.6
2019-01-01
Theranostics
Abstract:<b>Rationale</b>: PD1/PD-L1 immune checkpoint inhibitors have shown promising results for several malignancies. However, PD1/PD-L1 signaling and its therapeutic significance remains largely unknown in intrahepatic cholangiocarcinoma (ICC) cases with complex etiology. <b>Methods</b>: We investigated the expression and clinical significance of CD3 and PD1/PD-L1 in 320 ICC patients with different risk factors. In addition, we retrospectively analyzed 7 advanced ICC patients who were treated with PD1 inhibitor. <b>Results</b>: The cohort comprised 233 patients with HBV infection, 18 patients with hepatolithiasis, and 76 patients with undetermined risk factors. PD-L1 was mainly expressed in tumor cells, while CD3 and PD1 were expressed in infiltrating lymphocytes of tumor tissues. PD1/PD-L1 signals were activated in tumor tissues, and expression was positively correlated with HBV infection and lymph node invasion. More PD1<sup>+</sup> T cells and higher PD-L1 expression were observed in tumor tissues of ICC patients with HBV infection compared to patients with hepatolithiasis or undetermined risk factors. More PD1<sup>+</sup> T cells and/or high PD-L1 expression negatively impacted the prognosis of patients with HBV infection but not those with hepatolithiasis. Multivariate analysis showed PD1/PD-L1 expression was an independent indicator of ICC patient prognosis. Advanced ICC patients with HBV infection and less PD1<sup>+</sup> T cells tended to have good response to anti-PD1 therapy. <b>Conclusion</b>: Hyperactivated PD1/PD-L1 signals in tumor tissues are a negative prognostic marker for ICCs after resection. HBV infection- and hepatolithiasis-related ICCs have distinct PD1/PD-L1 profiles. Further, PD1<sup>+</sup> T cells could be used as a biomarker to predict prognosis and assay the efficiency of anti-PD1 immunotherapy in ICC patients with HBV infection.
medicine, research & experimental
What problem does this paper attempt to address?